Reconsidering the age thresholds for type II diabetes screening in the U.S.

American Journal of Preventive Medicine

Volumn 47, Issue 4, 2014, Pages 375-381

  Chung, Sukyung ^a   Azar, Kristen M J ^a   Baek, Marshall ^a   Lauderdale, Diane S ^c   Palaniappan, Latha P ^a,b  

^a PALO ALTO MEDICAL FOUNDATION RESEARCH INSTITUTE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; HEALTH CARE COST; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MASS SCREENING; MEDICAL FEE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRACTICE GUIDELINE; RISK FACTOR; UNITED STATES; ADOLESCENT; AGED; COMPLICATION; DIABETES MELLITUS, TYPE 2; NUTRITION; OVERWEIGHT; PREVALENCE; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; HUMANS; MASS SCREENING; MIDDLE AGED; NUTRITION SURVEYS; OBESITY; OVERWEIGHT; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84920926908     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2014.05.012     Document Type: Article

References (35)

1. American Diabetes Association. Data from the 2011 National Diabetes Fact Sheet, 2011. diabetes.org/diabetes-basics/diabetes-statistics/?print=t.
2. National Institute of Diabetes and Digestive and Kidney Diseases. National Diabetes Statistics, 2011. diabetes.niddk.nih.gov/dm/pubs/statistics/#fast.
3. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346(6):393-403.
4. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20(4):537-44.
5. Colagiuri S, Cull CA, Holman RR. Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes?: U. K. prospective diabetes study 61. Diabetes Care 2002;25(8):1410-7.
6. Patel P, Macerollo A. Diabetes mellitus: diagnosis and screening. Am Fam Physician 2010;81(7):863-70.
7. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care 2013;36(S1):S11-S66.
8. U. S. Preventive Services Task Force. Screening for type 2 diabetes mellitus in adults. U. S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;148(11):846-54.
9. Handelsman Y, Mechanick JI, Blonde L, et al. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: executive summary. Endocr Pract 2011;17(2):287-302.
10. Pottie K, Jaramillo A, Lewin G, et al. Recommendations on screening for type 2 diabetes in adults. CMAJ 2012;184(15):1687-96.
11. Rutten G. Screening for type 2 diabetes-where are we now? Lancet 2010;375(9723):1324-6.
12. Koopman RJ, Mainous AG 3rd, Diaz VA, Geesey ME. Changes in age at diagnosis of type 2 diabetes mellitus in the U. S., 1988 to 2000. Ann Fam Med 2005;3(1):60-3.
13. Centers for Medicare and Medicaid Services. Clinical laboratory fee schedule, 2010. cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ClinicalLabFeeSched/clinlab.html.
14. Casagrande SS, Cowie CC, Fradkin JE. Utility of the U. S. Preventive Services Task Force criteria for diabetes screening. Am J Prev Med 2013;45(2):167-74.
15. Sheehy AM, Flood GE, Tuan WJ, Liou JI, Coursin DB, Smith MA. Analysis of guidelines for screening diabetes mellitus in an ambulatory population. Mayo Clin Proc 2010;85(1):27-35.
16. Chung S, Azar KMJ, Zhao B, Lauderdale DS, Palaniappan L. Diabetes screening and detection in an ambulatory clinical population. Proceedings of the 19th annual HMO Research Network Conference; 2013 April 16-18; San Francisco CA.
17. Li R, Zhang P, Barker LE, Chowdhury FM, Zhang X. Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review. Diabetes Care 2010;33(8):1872-94.
18. Kahn R, Alperin P, Eddy D, et al. Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis. Lancet 2010;375(9723):1365-74.
19. CDC. National Health Interview Survey 2009. census.gov/compendia/statab/cats/health-nutrition/health-care-utilization.html.
20. Khunti K, Davies M. Should we screen for type 2 diabetes: yes. BMJ 2012;345:e4514.
21. Gillies CL, Abrams KR, Lambert PC, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 2007;334(7588):299.
22. Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009;374(9702):1677-86.
23. Shanks L, Klarkowski D, O'Brien DP. False positive HIV diagnoses in resource limited settings: operational lessons learned for HIV programmes. PLoS One 2013;8(3):e59906.
24. Ilic D, Neuberger MM, Djulbegovic M, Dahm P. Screening for prostate cancer. Cochrane Database Syst Rev 2013;1:CD004720.
25. Kerlikowske K, Zhu W, Hubbard RA, et al. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med 2013;173(9):807-16.
26. Diabetes Prevention Program Research Group. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care 2002;25(12):2165-71.
27. Blackburn G. Effect of degree of weight loss on health benefits. Obes Res 1995 (3S2):S211-S216.
28. Simmons RK, Echouffo-Tcheugui JB, Griffin SJ. Screening for type 2 diabetes: an update of the evidence. Diabetes Obes Metab 2010;12(10):838-44.
29. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352(9131):837-53.
30. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010;362(9):800-11.
31. Ackermann RT, Cheng YJ, Williamson DF, Gregg EW. Identifying adults at high risk for diabetes and cardiovascular disease using hemoglobin A1c National Health and Nutrition Examination Survey 2005-2006. Am J Prev Med 2011;40(1):11-7.
32. Brosnan CA, Upchurch S, Schreiner B. Type 2 diabetes in children and adolescents: an emerging disease. J Pediatr Health Care 2001;15(4):187-93.
33. Mayer-Davis EJ. Type 2 diabetes in youth: epidemiology and current research toward prevention and treatment. J Am Diet Assoc 2008;108(4S1):S45-S51.
34. Pettitt DJ, Talton J, Dabelea D, et al. Prevalence of diabetes in U. S. youth in 2009: the SEARCH for diabetes in youth study. Diabetes Care 2014;37(2):402-8.
35. Harris MI, Eastman RC. Early detection of undiagnosed diabetes mellitus: a U. S. perspective. Diabetes Metab Res Rev 2000;16(4):230-6.